BRUSSELS/BARCELONA (Reuters) - The European Medicines Agency approved on Friday two factories for the production of COVID-19 vaccines, with the European Union banking on them to boost deliveries in the second quarter and accelerate the slow pace of inoculations in the bloc.
The EMA said in statement it had cleared the Halix production site in the Netherlands that makes the AstraZeneca vaccine and a facility in Marburg in Germany producing BioNTech/Pfizer shots.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!